Följ
Marina Evangelou
Marina Evangelou
Verifierad e-postadress på imperial.ac.uk - Startsida
Titel
Citeras av
Citeras av
År
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
E Evangelou, HR Warren, D Mosen-Ansorena, B Mifsud, R Pazoki, H Gao, ...
Nature genetics 50 (10), 1412-1425, 2018
13612018
Widespread seasonal gene expression reveals annual differences in human immunity and physiology
XC Dopico, M Evangelou, RC Ferreira, H Guo, ML Pekalski, DJ Smyth, ...
Nature communications 6 (1), 7000, 2015
5412015
Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial
JA Todd, M Evangelou, AJ Cutler, ML Pekalski, NM Walker, HE Stevens, ...
PLoS medicine 13 (10), e1002139, 2016
1552016
Million Veteran Program
E Evangelou, HR Warren, D Mosen-Ansorena, B Mifsud, R Pazoki, H Gao, ...
Genetic analysis of over 1, 1412-1425, 1755
1141755
A method for gene‐based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations
M Evangelou, DJ Smyth, MD Fortune, OS Burren, NM Walker, H Guo, ...
Genetic epidemiology 38 (8), 661-670, 2014
792014
Comparison of methods for competitive tests of pathway analysis
M Evangelou, A Rendon, WH Ouwehand, L Wernisch, F Dudbridge
Public Library of Science 7 (7), e41018, 2012
662012
Integrating multi-OMICS data through sparse canonical correlation analysis for the prediction of complex traits: a comparison study
T Rodosthenous, V Shahrezaei, M Evangelou
Bioinformatics 36 (17), 4616-4625, 2020
552020
An anomaly detection framework for cyber-security data
M Evangelou, NM Adams
Computers & Security 97, 101941, 2020
462020
The link between attention deficit hyperactivity disorder (ADHD) symptoms and obesity-related traits: genetic and prenatal explanations
V Karhunen, TA Bond, V Zuber, T Hurtig, I Moilanen, MR Järvelin, ...
Translational Psychiatry 11 (1), 455, 2021
342021
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response …
LA Truman, ML Pekalski, P Kareclas, M Evangelou, NM Walker, J Howlett, ...
BMJ open 5 (12), e009799, 2015
292015
Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling
NA van Vliet, MM Bos, CS Thesing, L Chaker, M Pietzner, E Houtman, ...
BMC medicine 19, 1-13, 2021
252021
Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun 6: 7000
XC Dopico, M Evangelou, RC Ferreira, H Guo, ML Pekalski, DJ Smyth, ...
212015
Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study …
J Heywood, M Evangelou, D Goymer, J Kennet, K Anselmiova, C Guy, ...
Trials 16, 1-13, 2015
152015
Two novel pathway analysis methods based on a hierarchical model
M Evangelou, F Dudbridge, L Wernisch
Bioinformatics 30 (5), 690-697, 2014
142014
Predictability of netflow data
M Evangelou, NM Adams
2016 IEEE Conference on Intelligence and Security Informatics (ISI), 67-72, 2016
132016
Variational Bayes for high-dimensional proportional hazards models with applications within gene expression
M Komodromos, EO Aboagye, M Evangelou, S Filippi, K Ray
Bioinformatics 38 (16), 3918-3926, 2022
102022
Activity-based temporal anomaly detection in enterprise-cyber security
M Whitehouse, M Evangelou, NM Adams
2016 IEEE Conference on Intelligence and Security Informatics (ISI), 248-250, 2016
102016
Multi-view data visualisation via manifold learning
T Rodosthenous, V Shahrezaei, M Evangelou
PeerJ Computer Science 10, e1993, 2024
82024
Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining
C Frainay, Y Pitarch, S Filippi, M Evangelou, A Custovic
Clinical & Experimental Allergy 51 (9), 1185-1194, 2021
72021
MiR-139-5p is a causal biomarker for type 2 diabetes; Results from genome-wide microRNA profiling and Mendelian randomization analysis in a population-based study
MMJ Mens, R Mustafa, F Ahmadizar, MA Ikram, M Evangelou, M Kavousi, ...
medRxiv, 2021.05. 13.21257090, 2021
62021
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20